2011
DOI: 10.1684/abc.2011.0572
|View full text |Cite
|
Sign up to set email alerts
|

Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
45
0
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(48 citation statements)
references
References 0 publications
2
45
0
1
Order By: Relevance
“…Bolin et al [12] demonstrated that separate measurements of serum HRG and PI may predict pre-eclampsia, but by combining serum HRG and PI the accuracy increased. This is in line with this study in which a total accuracy of both reached 84.3% and in line with studies proposing a combination of biochemical and biophysical markers for a successful prediction of pre-eclampsia in early pregnancy [13,14,22,23].…”
Section: Figuresupporting
confidence: 92%
See 1 more Smart Citation
“…Bolin et al [12] demonstrated that separate measurements of serum HRG and PI may predict pre-eclampsia, but by combining serum HRG and PI the accuracy increased. This is in line with this study in which a total accuracy of both reached 84.3% and in line with studies proposing a combination of biochemical and biophysical markers for a successful prediction of pre-eclampsia in early pregnancy [13,14,22,23].…”
Section: Figuresupporting
confidence: 92%
“…Uterine artery Doppler ultrasonography is one of the best predictors of pre-eclampsia [13]. Doppler assessment of the uterine arteries is a noninvasive test suggested to reflect trophoblast invasion and development, as well as uteroplacental perfusion [14].…”
Section: Introductionmentioning
confidence: 99%
“…The most effective predictive models for pre-eclampsia have combined serum biomarker analysis with uterine artery waveform analysis and maternal demographic features (148). Sensitivities and specificities greater than 90% have been reported from retrospective analysis of serum levels of placental growth factor, pregnancy associated peptide A or placental protein 13 from samples collected in the first trimester with uterine artery Doppler and demographic data (148,150,155) but are yet to be validated in prospective cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…Placental protein 13 (PP13) is a serum marker of placental origin that is widely used to monitor the development of pregnancy [8,13,31]. The protein, also known as galectin 13, is exclusively produced in the syncytiotrophoblast layer of the placenta, from where it reaches the maternal blood circulation from as early as the 6 th week of gestation [3,17].…”
Section: Introductionmentioning
confidence: 99%